Register Cart 0

Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Back Subscribe

Editorial (Hot Topic: Anti-cancer Molecular Targets of Natural Products)

Author(s): Xiaolin Zi and Ruiwen Zhang

Volume 13, Issue 5, 2013

Page: [485 - 485] Pages: 1

DOI: 10.2174/1568009611313050001

Next »

Rights & Permissions Print Cite

Article Metrics

45

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Docking and QSAR Studies of Aryl-valproic Acid Derivatives to Identify Antiproliferative Agents Targeting the HDAC8
Anti-Cancer Agents in Medicinal Chemistry

Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery

Treatment for Cancer Patients with Oral Mucositis: Assessment Based on the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer in International Society of Oral Oncology (MASCC/ISOO) in 2013 and Proposal of Possible Novel Treatment with a Japanese Herbal Medicine
Current Pharmaceutical Design

Synthetic and Natural Coumarins as Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents

Estrogens and Colorectal Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential
Current Drug Metabolism

Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Current Drug Targets

Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model
Anti-Cancer Agents in Medicinal Chemistry

Meet the Editorial Board:
Protein & Peptide Letters

The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Current Topics in Medicinal Chemistry

Apoptosis in Drug Response
Current Pharmacogenomics

Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Current Molecular Medicine

Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Current Pharmaceutical Design

Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
Current Pharmaceutical Design

Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design

Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
Current Pharmaceutical Design

Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism

Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy

Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology

© 2024 Bentham Science Publishers | Privacy Policy